136 related articles for article (PubMed ID: 19201992)
1. Modulation of DNA methylation by a sesquiterpene lactone parthenolide.
Liu Z; Liu S; Xie Z; Pavlovicz RE; Wu J; Chen P; Aimiuwu J; Pang J; Bhasin D; Neviani P; Fuchs JR; Plass C; Li PK; Li C; Huang TH; Wu LC; Rush L; Wang H; Perrotti D; Marcucci G; Chan KK
J Pharmacol Exp Ther; 2009 May; 329(2):505-14. PubMed ID: 19201992
[TBL] [Abstract][Full Text] [Related]
2. Anticancer activity profiling of parthenolide analogs generated via P450-mediated chemoenzymatic synthesis.
Alwaseem H; Frisch BJ; Fasan R
Bioorg Med Chem; 2018 Apr; 26(7):1365-1373. PubMed ID: 28826596
[TBL] [Abstract][Full Text] [Related]
3. Discovery of potent parthenolide-based antileukemic agents enabled by late-stage P450-mediated C-H functionalization.
Kolev JN; O'Dwyer KM; Jordan CT; Fasan R
ACS Chem Biol; 2014 Jan; 9(1):164-73. PubMed ID: 24206617
[TBL] [Abstract][Full Text] [Related]
4. Identification of a potential DNA methyltransferase (DNMT) inhibitor.
Jan Z; Ahmed WS; Biswas KH; Jithesh PV
J Biomol Struct Dyn; 2024 Jun; 42(9):4730-4744. PubMed ID: 37424222
[TBL] [Abstract][Full Text] [Related]
5. Crystal Structures and Human Leukemia Cell Apoptosis Inducible Activities of Parthenolide Analogues Isolated from Piptocoma rufescens.
Ren Y; Gallucci JC; Li X; Chen L; Yu J; Kinghorn AD
J Nat Prod; 2018 Mar; 81(3):554-561. PubMed ID: 29350920
[TBL] [Abstract][Full Text] [Related]
6. Lessons learned from the discovery and development of the sesquiterpene lactones in cancer therapy and prevention.
Cheikh IA; El-Baba C; Youssef A; Saliba NA; Ghantous A; Darwiche N
Expert Opin Drug Discov; 2022 Dec; 17(12):1377-1405. PubMed ID: 36373806
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic targeting of DNA methylation alterations in cancer.
Lee AV; Nestler KA; Chiappinelli KB
Pharmacol Ther; 2024 Jun; 258():108640. PubMed ID: 38570075
[TBL] [Abstract][Full Text] [Related]
8. Green nanotech paradigm for enhancing sesquiterpene lactone therapeutics in cancer.
Zahra M; Abrahamse H; George BP
Biomed Pharmacother; 2024 Apr; 173():116426. PubMed ID: 38471274
[TBL] [Abstract][Full Text] [Related]
9. Quinoline-based compounds can inhibit diverse enzymes that act on DNA.
Zhou J; Chen Q; Ren R; Yang J; Liu B; Horton JR; Chang C; Li C; Maksoud L; Yang Y; Rotili D; Zhang X; Blumenthal RM; Chen T; Gao Y; Valente S; Mai A; Cheng X
bioRxiv; 2024 Apr; ():. PubMed ID: 38617249
[TBL] [Abstract][Full Text] [Related]
10. Identification of dihydromyricetin as a natural DNA methylation inhibitor with rejuvenating activity in human skin.
Falckenhayn C; Bienkowska A; Söhle J; Wegner K; Raddatz G; Kristof B; Kuck D; Siegner R; Kaufmann R; Korn J; Baumann S; Lange D; Schepky A; Völzke H; Kaderali L; Winnefeld M; Lyko F; Grönniger E
Front Aging; 2023; 4():1258184. PubMed ID: 38500495
[TBL] [Abstract][Full Text] [Related]
11. Derivatisation of parthenolide to address chemoresistant chronic lymphocytic leukaemia.
Li X; Payne DT; Ampolu B; Bland N; Brown JT; Dutton MJ; Fitton CA; Gulliver A; Hale L; Hamza D; Jones G; Lane R; Leach AG; Male L; Merisor EG; Morton MJ; Quy AS; Roberts R; Scarll R; Schulz-Utermoehl T; Stankovic T; Stevenson B; Fossey JS; Agathanggelou A
Medchemcomm; 2019 Aug; 10(8):1379-1390. PubMed ID: 32952998
[TBL] [Abstract][Full Text] [Related]
12. Parthenolide, a sesquiterpene lactone, expresses multiple anti-cancer and anti-inflammatory activities.
Mathema VB; Koh YS; Thakuri BC; Sillanpää M
Inflammation; 2012 Apr; 35(2):560-5. PubMed ID: 21603970
[TBL] [Abstract][Full Text] [Related]
13. Modulation of the vitamin D receptor by traditional Chinese medicines and bioactive compounds: potential therapeutic applications in VDR-dependent diseases.
Yao M; Oduro PK; Akintibu AM; Yan H
Front Pharmacol; 2024; 15():1298181. PubMed ID: 38318147
[TBL] [Abstract][Full Text] [Related]
14. Recent progress in DNA methyltransferase inhibitors as anticancer agents.
Zhang Z; Wang G; Li Y; Lei D; Xiang J; Ouyang L; Wang Y; Yang J
Front Pharmacol; 2022; 13():1072651. PubMed ID: 37077808
[TBL] [Abstract][Full Text] [Related]
15. Investigation of targets and anticancer mechanisms of covalently acting natural products by functional proteomics.
Zhao WS; Chen KF; Liu M; Jia XL; Huang YQ; Hao BB; Hu H; Shen XY; Yu Q; Tan MJ
Acta Pharmacol Sin; 2023 Aug; 44(8):1701-1711. PubMed ID: 36932232
[TBL] [Abstract][Full Text] [Related]
16. Thymoquinone, piperine, and sorafenib combinations attenuate liver and breast cancers progression: epigenetic and molecular docking approaches.
El-Shehawy AA; Elmetwalli A; El-Far AH; Mosallam SAE; Salama AF; Babalghith AO; Mahmoud MA; Mohany H; Gaber M; El-Sewedy T
BMC Complement Med Ther; 2023 Mar; 23(1):69. PubMed ID: 36870998
[TBL] [Abstract][Full Text] [Related]
17. The FDA-approved drug Auranofin has a dual inhibitory effect on SARS-CoV-2 entry and NF-κB signaling.
Laplantine E; Chable-Bessia C; Oudin A; Swain J; Soria A; Merida P; Gourdelier M; Mestiri S; Besseghe I; Bremaud E; Neyret A; Lyonnais S; Favard C; Benaroch P; Hubert M; Schwartz O; Guerin M; Danckaert A; Del Nery E; Muriaux D; Weil R
iScience; 2022 Oct; 25(10):105066. PubMed ID: 36093378
[TBL] [Abstract][Full Text] [Related]
18. Antiproliferative and cytotoxic effects of sesquiterpene lactones isolated from
Kovács B; Szemerédi N; Kúsz N; Kiss T; Csupor-Löffler B; Tsai YC; Rácz B; Spengler G; Csupor D
Pharm Biol; 2022 Dec; 60(1):1511-1519. PubMed ID: 35952383
[TBL] [Abstract][Full Text] [Related]
19. The Emerging Potential of Parthenolide Nanoformulations in Tumor Therapy.
An T; Yin H; Lu Y; Liu F
Drug Des Devel Ther; 2022; 16():1255-1272. PubMed ID: 35517982
[TBL] [Abstract][Full Text] [Related]
20. Parthenolide Suppresses T Helper 17 and Alleviates Experimental Autoimmune Encephalomyelitis.
Zhang Z; Zhang K; Zhang M; Zhang X; Zhang R
Front Immunol; 2022; 13():856694. PubMed ID: 35514960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
